VAERS 2021 Database www.vaers.hhs.gov

Main Page | All 2021 Deaths | Videos
VAERS Updated: 11/12/2021
** VAERS DATABASE Last updated: November 12, 2021**
PLEASE CHECK BACK SOON
Download the files above while you wait.







Manufacturers

Total Manufacturer
46,870MODERNA
532GLAXOSMITHKLINE BIOLOGICALS
353PFIZER\BIONTECH
231MERCK & CO. INC.
221UNKNOWN MANUFACTURER
62SEQIRUS, INC.
25DYNAVAX TECHNOLOGIES CORPORATION
13EMERGENT BIOSOLUTIONS
12SANOFI PASTEUR
9NOVARTIS VACCINES AND DIAGNOSTICS
5PFIZER\WYETH
5PAXVAX
2TEVA PHARMACEUTICALS
2PROTEIN SCIENCES CORPORATION
1BERNA BIOTECH, LTD.
1INTERCELL AG
1CSL LIMITED

COVID19 Lot Number

VAX LOT Total
2S9CL1,906
1,575
289
IMM209286
252
236
229
s029456178
171
UT7065MA166
155
149
145
S034636133
107
U62828AA103
100
98
P10025327596
U6737AA85
UJ446AA79
78
78
59
57
4BH3254
4F47253
52
27656352
50
PP9L548
49TM346
42
40
38
MENVEO38
4F47237
R1B252M36
34
C5763AA30
93362229
25
300057A24
UNK24
22
CW311621
18
17
15
UH894AB15
3Y7NL12
R1B743M12
EJ168611
el128410
10
10
10
9
ARBA141A9
UNK9
8
UNK8
8
1F4EB8
Unknown7
7
No batch number6
5
5
UJ090AA5
5
5
4
4
4
UNK4
JEV18K95E4
UNK3
A115A3
Z127A3
3
3333324181073
2
2
2
TAR352
1
1
1
1
1
A739081
1
1
1
1
1
037K20A68,542
EL128447,700
133

Incidents per State

State Total
15,185
CA14,096
NY7,507
TX7,196
FL6,939
IN5,527
PA4,560
IL4,179
OH4,054
AZ3,856
MI3,771
NJ3,411
MA3,278
VA3,208
NC3,114
WA3,034
GA2,864
MD2,652
MN2,534
CO2,532
WI2,457
MO2,029
OR1,943
TN1,715
CT1,693
KY1,603
OK1,226
AL1,201
KS1,162
IA1,157
SC1,106
NM1,065
UT973
AR951
LA945
NE829
NV797
ME795
MT789
NH756
ID674
AK661
WV661
PR650
MS585
HI536
RI510
VT441
SD361
ND356
DE350
DC239
WY209
GU32
AS16
VI13
MP9
MH3
FM2
QM1
XB1

ID: 0999955
Sex: F
Age:
State:

Vax Date: 12/25/2020
Onset Date:
Rec V Date: 02/04/2021
Hospital:

Lab Data:

Allergies:

Symptoms: arm pain; redness; This is a spontaneous report from a contactable other healthcare professional (patient) and a consumer (husband). A 68-year-old female patient received the first dose bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on 25Dec2020 at a single dose for covid-19 immunization. The patient's medical history included a heart attack 20 years ago; coronary artery disease and autoimmune deficiency (ATS) from an unknown date. Concomitant medication included clopidogrel bisulfate (PLAVIX), warfarin sodium (COUMADIN). The patient experienced arm pain and redness on an unspecified date with outcome of recovered. Information about lot/batch number has been requested.

Other Meds: PLAVIX; COUMADIN

Current Illness:

ID: 0999956
Sex: F
Age:
State: NY

Vax Date: 01/17/2021
Onset Date: 01/17/2021
Rec V Date: 02/04/2021
Hospital:

Lab Data:

Allergies:

Symptoms: next to nose below right eye had the feeling of something burning/getting a feeling on face below her eye, it felt like a burning sensation; like an irritant on skin; hurt, next to my nose and as the night went on it stayed there, moving lower today; getting little red blister or some type of little things/like a little blister pustule thing, now inside lip/blisters started forming down her cheek, she can feel them still forming; getting little red blister or some type of little things/like a little blister pustule thing, now inside my lip/the blisters are down to her mouth now and there is even one inside her lip; getting little red blister or some type of little things/like a little blister pustule thing, now inside my lip/the blisters are down to her mouth now and there is even one inside her lip; This is a spontaneous report from a contactable nurse (patient). A female patient of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, lot number and expiration date not provided), via an unspecified route of administration on 17Jan2021 at single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The caller was a retired nurse who reported that she got the covid vaccine yesterday afternoon on 17Jan2021. She reported that about 30 minutes after getting the vaccine on 17Jan2021 she noticed "that next to my nose below right eye I had the feeling of something burning, like an irritant on my skin, like jalapeno pepper juice or something. It hurt, next to my nose and as the night went on it stayed there, moving lower today and getting little red blister or some type of little things. I looked in the mirror, and it's like a little blister pustule thing, now inside my lip". Caller stated that she was trying to decide if she needs to go to Urgent Care. Caller states that she got home after getting the COVID vaccine, she was there for 15 minutes for observation and then within a half hour of her getting home afterwards, she started getting a feeling on her face below her eye, it felt like a burning sensation, like jalapeno pepper juice, like an irritant type burning. Caller states that little by little, blisters started forming down her cheek, she can feel them still forming. Caller states that the blisters are down to her mouth now and there is even one inside her lip. Caller was wondering if this vaccine triggered a shingles outbreak in her, even though she has never had shingles before. But caller stated that she knew people can pop out with shingles after something like this, but she was just speculating, she did not know for sure that it is shingles. The outcome of the events was unknown. This case reported as non-serious. Information on the LOT/Batch number has been requested.

Other Meds:

Current Illness:

ID: 0999957
Sex: F
Age:
State: MA

Vax Date: 01/16/2021
Onset Date: 01/16/2021
Rec V Date: 02/04/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Next morning splitting headache woke me up at 5 am. Took Advil. 3 hours later still headache w/nausea.; Next morning splitting headache woke me up at 5 am. Took Advil. 3 hours later still headache w/nausea.; 3 hours later woke up with sweats.; Few hours after dose fatigue.; In the evening, leg weakness and achy all over.; In the evening, leg weakness and achy all over.; This is a spontaneous report from a contactable nurse (patient). This 50-year-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration at left arm on 16Jan2021 09:15 AM at single dose for covid-19 immunisation. Medical history was unknown. Concomitant medications were none. The patient experienced few hours after dose fatigue at 02:00 PM on 16Jan2021. In the evening of 16Jan2021, the patient had leg weakness and achy all over. Next morning on 17Jan2021, splitting headache woke the patient up at 5 am. The patient took Advil as treatment for headache. 3 hours later the patient still had headache with nausea. 3 hours later she woke up with sweats. Then she started feeling better. The patient woke up this morning slight headache only and resolved on own couple hours later. No treatment was received for the events except headache. The patient had no other vaccine in four weeks or other medications in two weeks. The patient had no covid tested post vaccination, no known allergies. Outcome of all events was recovered. Information on the lot/batch number has been requested.

Other Meds:

Current Illness:

ID: 0999958
Sex: F
Age:
State: MI

Vax Date: 01/18/2021
Onset Date: 01/18/2021
Rec V Date: 02/04/2021
Hospital:

Lab Data: Test Date: 20210118; Test Name: Heart rate; Result Unstructured Data: Test Result:went to 140; Test Date: 20210118; Test Name: Heart rate; Result Unstructured Data: Test Result:went down

Allergies:

Symptoms: Arm pain happened 4 hours after vaccination.; Dizziness; weakness; heart rate went to 140 30 minutes after the shot. Heart rate went down 1 hour after; This is a spontaneous report from a contactable consumer. This 25-year-old female consumer (patient) reported that she received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) at single dose for COVID-19 immunization on 18Jan2021 at 13:00. Relevant history and concomitant drugs were unknown. No known allergies. No other medical history. The patient received her first dose of BNT162B2 on unknown date. The patient experienced dizziness and weakness on 18Jan2021 at 01:45 pm. The heart rate went to 140 30 minutes after the shot. Heart rate went down 1 hour later, but she was still having dizziness. The patient also had arm pain 4 hours after vaccination on 18Jan2021. No treatment was received. The outcome of event was recovering. The patient did not receive any other vaccine in four weeks. The patient did not have COVID infection prior vaccination. The patient did have COVID test post vaccination. Information about Lot/Batch number is requested.

Other Meds:

Current Illness:

ID: 0999959
Sex: F
Age:
State:

Vax Date: 01/13/2021
Onset Date: 01/01/2021
Rec V Date: 02/04/2021
Hospital:

Lab Data: Test Name: blood workup; Result Unstructured Data: Test Result:Unknonwn results

Allergies:

Symptoms: felt very tired; This is a spontaneous report from a contactable consumer (patient). An 82-year-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot number and expiry date unknown) via unspecified route of administration on 13Jan2021 at single dose for Covid-19 immunization. The patient's medical history and concomitant medications were not reported. The patient received first dose of COVID vaccine on 13Jan2021 and was scheduled to receive second dose on 02Feb2021. In Jan2021, the patient felt very tired after first dose. The patient informed that she usually walks two miles per day and since the first dose of vaccine she has only been able to walk one mile. The patient informed that she was able to walk two miles yesterday. The patient informed that she was set up for major dental work to include implant capping of two teeth and cancelled her appointment for today. The patient wanted to know if she should put off having her dental work done until after the second dose of the vaccine as she has another appointment scheduled for next Monday. The patient informed that she went to her rheumatologist for blood workup and she can only have blood work done on one arm. The patient wanted to know how long does she have to wait after second dose to have blood work drawn in same arm. The outcome of the event felt very tired was unknown. Follow-up activities are possible, information on the batch number has been requested.

Other Meds:

Current Illness:

ID: 0999960
Sex: F
Age:
State: TX

Vax Date: 01/17/2021
Onset Date: 01/17/2021
Rec V Date: 02/04/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Body aches; fatigue; sore throat; chills; This is a spontaneous report from a contactable nurse who reported for herself. A 44-year-old female patient received her second single dose of BNT162B2 (Pfizer-BioNTech Covid-19 vaccine, lot number EL9261) at her right arm 08:30 AM on 17Jan2021 for Covid-19 immunization. The patient received her first shot (lot number EL0140) at right arm 08:30AM on 27Dec2020. The patient had a medical history included asthma, anxiety, hyperlipidemia. Patient had no known allergies. Concomitant medications included fluticasone propionate, salmeterol xinafoate (ADVAIR), duloxetine, salbutamol (ALBUTEROL), rosuvastatin calcium (CRESTOR), and montelukast sodium (SINGULAIR). 06:30 PM on 17Jan2021, the patient experienced body aches, fatigue, sore throat, and chills. No treatment was received for the events. The outcome of the events was not resolved at the time of reporting. Patient had no COVID prior vaccination and had not COVID tested post vaccination.

Other Meds: ADVAIR; DULOXETINE; ALBUTEROL [SALBUTAMOL]; CRESTOR; SINGULAIR

Current Illness:

ID: 0999961
Sex: F
Age:
State: CA

Vax Date: 01/11/2021
Onset Date: 01/11/2021
Rec V Date: 02/04/2021
Hospital:

Lab Data:

Allergies:

Symptoms: facial swelling; This is a spontaneous report from a contactable nurse (patient). A 40-year-old female patient received second dose of bnt162b2 BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EJ1686), via an unspecified route of administration in left arm om 11Jan2021 09:30 at single dose for COVID-19 immunization. Medical history included seasonal allergies and urinary incontinence from an unknown date and unknown if ongoing. Concomitant medication included cetirizine, atenolol (NORTELOL) and oxybutynin. The patient was previously vaccinated with first dose of BNT162B2 (lot number: EH9899) via unspecified route in right arm ,on 22Dec2020 09:30 AM, for COVID-19 immunization. The patient was not pregnant. The facility where the most recent COVID-19 vaccine was administered was in the hospital. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19. The patient experienced facial swelling on 11Jan2021 18:00 treated with diphenyhydramine (self administered). The outcome of the event was recovered on unspecified date.

Other Meds: CETIRIZINE; NORTELOL; OXYBUTYNIN

Current Illness:

ID: 0999962
Sex: F
Age:
State: FL

Vax Date: 12/26/2020
Onset Date:
Rec V Date: 02/04/2021
Hospital:

Lab Data:

Allergies:

Symptoms: sore arm; This is a spontaneous report from a contactable consumer (patient). A 58-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) (Lot # EH9199) via an unspecified route of administration in left arm on 26Dec2020 at single dose for COVID-19 immunisation. The patient medical history and concomitant medications were not reported. The patient experienced sore arm on an unspecified date with outcome of unknown.

Other Meds:

Current Illness:

ID: 0999963
Sex: M
Age:
State: AK

Vax Date: 12/23/2020
Onset Date: 12/24/2020
Rec V Date: 02/04/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Splitting trident occipital headache/ Dull ache in frontal skull region; This is a spontaneous report from a contactable other healthcare professional (patient). A 34-year-old male patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE lot number: EK5730, expiration date not reported) via an unspecified route of administration on the left arm on 23Dec2020 16:00 at a single dose for COVID-19 immunization. Medical history included asthma, rheumatoid arthritis, Raynaud's and allergies: latex, nickel, erythromycin. Concomitant medication included albuterol [salbutamol] (ALBUTEROL [SALBUTAMOL]), mometasone furoate (FLONASE [MOMETASONE FUROATE]), vitamin c [ascorbic acid] (VITAMIN C [ASCORBIC ACID]), colecalciferol (VITAMIN D [COLECALCIFEROL]) and multivitamin. On 24Dec2020, 1 day post 1st injection the patient had splitting trident occipital headache - lasted 24 hrs. Dull ache in frontal skull region two days after that. No treatment was received. The facility where the vaccine was administered was the workplace clinic. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Post vaccination, the patient has not been tested for COVID-19. Outcome of the event was unknown.

Other Meds: ALBUTEROL [SALBUTAMOL]; FLONASE [MOMETASONE FUROATE]; VITAMIN C [ASCORBIC ACID]; VITAMIN D [COLECALCIFEROL]

Current Illness:

ID: 0999964
Sex: F
Age:
State: CA

Vax Date: 12/18/2020
Onset Date: 01/03/2021
Rec V Date: 02/04/2021
Hospital:

Lab Data: Test Name: ultrasound of both sides of chest and both clavicle areas; Result Unstructured Data: Test Result:Unknown Results; Test Name: ultrasound of both sides of chest and both clavicle areas; Result Unstructured Data: Test Result:Unknown Results

Allergies:

Symptoms: Lymph node swelling noticed in the left clavicle area/swollen lymph node around her left clavicle; Lymph node swelling noticed in the left clavicle area/Did hurt at the beginning; This is a spontaneous report from a contactable nurse (patient). A female patient of an unspecified age received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration in left arm on 18Dec2020 at single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. On 03Jan2021, the patient experienced lymph node swelling noticed in the left clavicle area. No pain now but did hurt at the beginning "for a few days." The patient stated her doctor did an ultrasound of both sides of chest and both clavicle areas: unknown result. The patient was asking if this has been reported in other patients. The patient stated, "I have read everything on lymph edema, I want some specific information regarding the swollen lymph node around my left clavicle. I am really concerned because nobody can tell me anything. I am a nurse and if this is normal side effect from the vaccine then tell me or do I need to get a biopsy for lymphoma?". The outcome of the events was recovered in Jan2021. Information on the Batch/Lot number has been requested.

Other Meds:

Current Illness:

ID: 0999965
Sex: M
Age:
State: MI

Vax Date: 01/12/2021
Onset Date: 01/12/2021
Rec V Date: 02/04/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Pulsating muscle back pain; This is a spontaneous report from a contactable consumer (patient). An 83-year-old male patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot number: EK9231, expiration date unknown), via an unspecified route of administration in the right arm on 12Jan2021 at 11:00 AM at a single dose for COVID-19 immunization. Medical history included advanced prostate cancer and penicillin allergies. The patient had no COVID prior to vaccination. Concomitant medications included prednisone, amlodipine, losartan, and enzalutamide (XTANDI) given on unknown dates for unspecified indications. Patient has not had other vaccine in four weeks. On 12Jan2021 at 15:00, the patient experienced pulsating muscle back pain. The patient has not been tested for COVID post vaccination. Therapeutic measures were taken as a result of the event which included unspecified OTC medicine. The outcome of the event was recovering.

Other Meds: PREDNISONE; AMLODIPINE; LOSARTAN; XTANDI

Current Illness:

ID: 0999966
Sex: M
Age:
State: FL

Vax Date: 01/18/2021
Onset Date: 01/18/2021
Rec V Date: 02/04/2021
Hospital:

Lab Data:

Allergies:

Symptoms: a mild rash on my forearms and front of my legs; numb tongue; This is a spontaneous report from a contactable consumer (patient). A 65-year-old male patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) via an unspecified route of administration on 18Jan2021 14:30 at a single dose for covid-19 immunisation. Medical history included mild hypertension, elevated cholesterol, allergy to sulfa, allergy to gluten and celiac disease. The patient's concomitant medications were not reported. On 18Jan2021 15:30, patient experienced mild rash on his forearms and front of his legs which was treated with diphenhydramine (BENADRYL) tablet. The patient also experienced numb tongue on 18Jan2021 15:30 with no treatment received. Outcome of event "mild rash on my forearms and front of my legs" was unknown while for the event "numb tongue" was not recovered. Information on the Lot/Batch number has been requested.

Other Meds:

Current Illness:

ID: 0999967
Sex: F
Age:
State: MN

Vax Date: 01/13/2021
Onset Date: 01/13/2021
Rec V Date: 02/04/2021
Hospital:

Lab Data:

Allergies:

Symptoms: light headed; vertigo; feel flushed; headache; This is a spontaneous report from a contactable healthcare professional reporting for self. This 60-year-old female patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number=ELC142) via intramuscular on 13Jan2021 08:30 AM (vaccine location=Left arm) at single dose for Covid-19 immunisation. Medical history included allergies: Reactive airway to chemicals/perfumes/smoke. Concomitant medications included calcium carbonate, colecalciferol (VITAMIN D 2000), calcium, fish oil, echinacea purpurea root, olea europaea leaf, sambucus nigra fruit (ELDERBERRY ECHINACEA & OLIVE LEAF). The patient previously received first dose of BNT162B2 (lot number=EJ1685) via intramuscular on 23Dec2020 08:30 AM (vaccine location=Left arm) at single dose for Covid-19 immunisation. No other vaccine in four weeks. On 13Jan2021, the patient had a headache in the evening and took Ibuprofen before bed. She woke up about 3:30 AM 14Jan2021 to use the bathroom and had vertigo. She carefully maneuvered to the bathroom and back to the bedroom, drank some Powerade and sat on the bed for a bit before she slowly laid back down. She did feel flushed while experiencing the vertigo. She was able to get back to sleep for a few more hours. When she got up about 7:15 am she felt light headed but did not have any more vertigo. Treatment for event headache included Ibuprofen, no treatment received for other events. Patient did not have COVID prior vaccination, did not test COVID post vaccination, patient was not pregnant. The outcome of events was recovered.

Other Meds: VITAMIN D 2000; CALCIUM; FISH OIL; ELDERBERRY ECHINACEA & OLIVE LEAF

Current Illness:

ID: 0999968
Sex: F
Age:
State: WA

Vax Date: 01/17/2021
Onset Date: 01/18/2021
Rec V Date: 02/04/2021
Hospital:

Lab Data: Test Date: 20210118; Test Name: fever; Result Unstructured Data: Test Result:101.4

Allergies:

Symptoms: a fever of 101.4; headache; fatigue; severe body aches; chills; nausea; This is a spontaneous report from a contactable other HCP (patient). A 29-year-old female patient received the second dose of bnt162b2 (lot number: EL1283), via an unspecified route of administration in left arm on 17Jan2021 15:00 at single dose for covid-19 immunization. Medical history included attention deficit hyperactivity disorder (ADHD), allergic rhinitis. Concomitant medication included dexamfetamine (DEXTROAMPHETAMINE), cetirizine, and unspecified prenatal multivitam. The patient previously received the first dose of bnt162b2 (lot number: Eh9899), via an unspecified route of administration in left arm on 30Dec2020 10:00 at single dose for covid-19 immunization. Starting 12 hours after 2nd vaccination (18Jan2021 03:00) patient developed severe body aches, chills, nausea. Within 18 hours after vaccination (18Jan2021 09:00) patient had also developed a fever of 101.4, headache, and fatigue. No treatment and pregnant. The outcome of the events was Recovering.

Other Meds: DEXTROAMPHETAMINE [DEXAMFETAMINE]; CETIRIZINE

Current Illness:

ID: 0999969
Sex: U
Age:
State: TN

Vax Date:
Onset Date:
Rec V Date: 02/04/2021
Hospital:

Lab Data:

Allergies:

Symptoms: have reactions to their recent botox injections; This is a spontaneous report from a non-contactable consumer communicated to a Pfizer colleague. This consumer reported similar events for 2 patients. This is 1st of two reports. A patient of unspecified age and gender received BNT162B2 (COVID-19 MRNA VACCINE BIONTECH), via an unspecified route of administration on an unspecified date at single dose for covid-19 immunisation. The patient medical history and concomitant medications were not reported. The patient had reactions to their recent injections on an unspecified date. Reported as "They provide various services. The outcome of the event was unknown. No follow-up attempts are possible; information about lot/batch number cannot be obtained.; Sender's Comments: Linked Report(s) : US-PFIZER INC-2021042317 Same reporter/ drug/ event for different patients

Other Meds:

Current Illness:

ID: 0999970
Sex: M
Age:
State: VA

Vax Date: 01/08/2021
Onset Date: 01/01/2021
Rec V Date: 02/04/2021
Hospital:

Lab Data:

Allergies:

Symptoms: large hive at injection site; scattered hives/smaller hives scattered; tightness in throat; thick feeling tongue; bubbled ulcer looking site on his lower left deltoid; left arm soreness; This is a spontaneous report from a contactable nurse (patient). A 45-year-old male patient received the second dose of BNT162B2 (Pfizer-BioNTech COVID-19 vaccine, lot number: EK4176), intramuscular on 08Jan2021 at a single dose on the left arm for COVID-19 immunization in the hospital. Medical history included allergies to penicillin (PCN), sulfa and latex. The patient did not have COVID-19 prior to vaccination. It was unknown if the patient had other vaccines in four weeks. The patient has other medications (unspecified) in two weeks. The patient previously took erythromycin (ERY) on an unspecified date and experienced allergies. The patient received the first dose of BNT162B2 (Pfizer-BioNTech COVID-19 vaccine, lot number: LEK5230) on 18Dec2020 at 08:00 AM via intramuscular route of administration on the right arm at a single dose for COVID-19 immunization and experienced hives, itching and itchy feeling tongue wherein the patient took Benadryl, 20 mg Pepcid and 10 mg of Zyrtec. After the second vaccine the patient experienced scattered hives, with large hive at injection site and smaller hives scattered on an unspecified date in Jan2021. The patient also had tightness in throat and thick feeling tongue also on unspecified dates in Jan2021. The patient took 50 mg Benadryl, 20 mg Pepcid, 10 mg of Zyrtec and albuterol inhaler with spacer four puffs. The patient also has a bubbled ulcer looking site on his lower left deltoid with left arm soreness eight days later both on an unspecified date in Jan2021. The outcome of the events bubbled ulcer looking site on his lower left deltoid and left arm soreness was unknown while the outcome of the other events was recovering. The patient has not been tested for COVID-19 post vaccination.

Other Meds:

Current Illness:

ID: 0999971
Sex: M
Age:
State: NC

Vax Date: 01/14/2021
Onset Date: 01/01/2021
Rec V Date: 02/04/2021
Hospital:

Lab Data: Test Name: blood test; Result Unstructured Data: Test Result:Unknown result

Allergies:

Symptoms: Terrible pain in back of neck/ very bad pains back of my neck; Shoulder pain; Headache comes and goes; Little nauseous; Feeling generally unwell; Short of breath; Muscle pain; This is a spontaneous report from a contactable consumer (patient). An 88-year-old male patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE solution for injection; lot number: EL3249; expiry date: unknown) via an unspecified route of administration, on 14Jan2021, at a single dose, for COVID-19 immunisation (to protect from the virus). Medical history included COVID-19 and he was in the hospital for 3 or 4 days. He came out 10 days later and it was negative. Other medical history included heart disorder. Concomitant medications included carvedilol (COREG) taken for many years because it strengthens his heart, apixaban (ELIQUIS) as blood thinner, finasteride, furosemide (LASIX), sotalol, spironolactone, and ezetimibe, simvastatin (VYTORIN). The patient received his first vaccination this past Thursday and everything was fine. He woke up the following morning (15Jan2021) with terrible/ very bad pains pain in back of his neck, shoulder and headache. He was a little nauseous, just feeling generally unwell, and short of breath. The headache comes and goes which he controlled with Tylenol. He also had muscle pain on an unspecified date in Jan2021. Tylenol was also taken for events muscle pain, shoulder pain, headache, and terrible pain in back of neck/ very bad pains back of my neck. He was wondering if there is anything, he should know and do about it. Patient underwent an unspecified blood test/ lab works with unknown results. Outcome of the events headache and short of breath was recovering, for event muscle pain was unknown, while for the remaining events was not recovered.

Other Meds: ELIQUIS; COREG; FINASTERIDE; LASIX [FUROSEMIDE]; SOTALOL; SPIRONOLACTONE; VYTORIN

Current Illness:

ID: 0999972
Sex: F
Age:
State:

Vax Date: 12/30/2020
Onset Date: 12/31/2020
Rec V Date: 02/04/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Hot flashes; chills; This is a spontaneous report received from a non-contactable Nurse. A 26-year-old female received dose 1 of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Lot number EK9231 and Expiration date was unspecified) on 30Dec2020 14:00 as single dose, (at 26 years of age), intramuscular left arm for COVID-19 immunisation. Medical history included allergic to shellfish. Concomitant medication was none. The Patient is not pregnant. The patient did not have Covid prior to vaccination. The patient was not tested post vaccination for Covid. No other vaccine was taken within four weeks. The patient did not have treatment. The patient experienced Hot flashes and chills 24hrs after receiving vaccine (31Dec2020 16:00). Outcome of event Hot flashes was recovered and chills was recovered. No follow-up attempts are possible. No further information expected.

Other Meds:

Current Illness:

ID: 0999973
Sex: F
Age:
State: AZ

Vax Date: 01/14/2021
Onset Date: 01/14/2021
Rec V Date: 02/04/2021
Hospital:

Lab Data: Test Date: 20201114; Test Name: Nasal Swab; Test Result: Negative

Allergies:

Symptoms: feel prickly; both arms broke out in raised hives and rash; both arms broke out in raised hives and rash; This is a spontaneous report from a contactable consumer (patient). A 49-years-old non-pregnant female patient received the first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number and expiration date: unknown), via an unspecified route of administration on the left arm on 14Jan2021 at 13:00 at a single dose for COVID-19 Immunization. Medical history included severe asthma, depression, anxiety, sinus problems, and known allergies with Penicillin and intravenous (IV) iodine. Concomitant medications included duloxetine hydrochloride (CYMBALTA) and aripiprazole (ABILIFY). The patient had no other vaccine in four weeks. The patient had no COVID prior vaccination. About 15 minutes after the shot, on 14Jan2021 at 1330 hours, the patient started to feel prickly and both arms broke out in raised hives and rash. Treatment for the events included intramuscular (IM) 50mg Benadryl. The events resulted in doctor or other healthcare professional office/clinic visit. The patient underwent lab tests and procedures which included nasal swab: negative on 14Nov2020. The events resolved in Jan2021. Information on the lot/batch number has been requested.

Other Meds: CYMBALTA; ABILIFY

Current Illness:

ID: 0999974
Sex: F
Age:
State: FL

Vax Date: 01/15/2021
Onset Date: 01/15/2021
Rec V Date: 02/04/2021
Hospital:

Lab Data:

Allergies:

Symptoms: non stop vomiting; headache; eyes hurt; cloudy feeling in my head; done nothing but Sleep; This is a spontaneous report from a contactable consumer (reporting for herself). A non-pregnant 19-year-old female patient received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE), via an unspecified route of administration on 15Jan2021 12:00 at a single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient previously received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE) for COVID-19 immunizatio. The patient experienced non-stop vomiting, headache, eyes hurt, cloudy feeling in my head and done nothing but sleep on 15Jan2021 14:00. There was no treatment received for the events. The outcome of the events was not recovered. The batch/lot number for the vaccine, BNT162B2, was not provided and will be requested during follow-up.

Other Meds:

Current Illness:

ID: 0999975
Sex: F
Age:
State: TN

Vax Date: 01/02/2021
Onset Date: 01/09/2021
Rec V Date: 02/04/2021
Hospital:

Lab Data: Test Date: 20210107; Test Name: Nasal Swab; Test Result: Negative

Allergies:

Symptoms: Widespread enlarged lymph nodes; Fatigue; Loss of appetite; This is a spontaneous report from a contactable healthcare professional (patient). A 34-year-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection), via an unspecified route of administration on left arm on 02Jan2021 at a single dose for COVID-19 immunization. There were no medical history and concomitant medications. The patient is not pregnant at the time of vaccination. The patient had no known allergies. The patient had no COVID prior vaccination. No other vaccine administered in four weeks and no other medications in two weeks. On 09Jan2021, the patient experienced widespread enlarged lymph nodes, fatigue and loss of appetite. The events resulted in doctor office/clinic and emergency room/department or urgent care visit. The treatment of the events included "Antibiotics to date". The patient was COVID-19 tested post vaccination on 07Jan2021, the COVID-19 test type post vaccination was Nasal Swab with negative result. The outcome of the events was not recovered. Information about Lot/Batch number has been requested.

Other Meds:

Current Illness:

ID: 0999976
Sex: F
Age:
State: FL

Vax Date: 01/11/2021
Onset Date: 01/12/2021
Rec V Date: 02/04/2021
Hospital:

Lab Data:

Allergies:

Symptoms: chills/major chills and could not warm up; was cold all night; This is a spontaneous report from a contactable consumer (patient). A 60-year-old female patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number and expiry date not reported), via an unspecified route of administration in the right arm on 11Jan2021 15:00 at single dose for COVID-19 immunisation. Medical history included allergies to sulfa. The patient was not pregnant at the time of vaccination. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient was not diagnosed with COVID-19 prior to vaccination. Since the vaccination, the patient has not been tested for COVID-19. Concomitant medications included citalopram, topiramate, zinc, and ergocalciferol (VIT D). On 12Jan2021 07:00, the patient started having chills in the morning that was gradually increasing throughout day. At 6:00pm, that patient had major chills and could not warm up. The patient got into the bed with numerous covers. She was cold all night. The last time she woke up was at 3:00am, and then when she woke at 6:00am, and she was fine. No treatment was received for feeling cold. Clinical outcome of the events was recovered on an unspecified date. Information about lot/batch number has been requested.

Other Meds: CITALOPRAM; TOPIRAMATE; ZINC; VIT D

Current Illness:

ID: 0999977
Sex: F
Age:
State: MI

Vax Date: 01/08/2021
Onset Date: 01/01/2021
Rec V Date: 02/04/2021
Hospital:

Lab Data:

Allergies:

Symptoms: typical site reaction at the time of injection/The spot was raised and turned bright red; typical site reaction at the time of injection/The spot was raised and turned bright red; typical site reaction at the time of injection/my arm was sore; I felt lethargic; hot to the touch; This is a spontaneous report from a contactable other healthcare professional (patient). A 41-year-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Lot number: EK9231) intramuscular on 08Jan2021 10:30 AM at single dose on the left arm for COVID-19 immunization. Patient is not pregnant. Medical history included unknown allergies(reported as "Known allergies: yes"). There were no other medical history. No COVID prior vaccination. Concomitant medications (Other medications in two weeks) included ibuprofen (ADVIL [IBUPROFEN]), fexofenadine hydrochloride (ALLEGRA 24 HOUR), diphenhydramine hydrochloride (BENADRYL) and montelukast sodium (SINGULAIR). No other vaccine in four weeks. Facility type vaccine is Hospital. The patient had a typical site reaction at the time of injection on 16Jan2021 09:00 AM. The spot was raised and turned bright red, and her arm was sore. The patient felt lethargic. After a few days those symptoms went away. The spot on her arm disappeared. Eight days later, the spot on her arm reappeared. It was bigger, bright red, and hot to the touch. Patient's arm felt sore again and she had lethargy again. A doctor confirmed it was not cellulitis. No treatment was given for the events. The events resulted in Doctor or other healthcare professional office/clinic visit. Patient was not tested for COVID-19 since the vaccination. Outcome of the events was recovering (as reported).

Other Meds: ADVIL [IBUPROFEN]; ALLEGRA 24 HOUR; BENADRYL; SINGULAIR

Current Illness:

ID: 0999978
Sex: F
Age:
State: MI

Vax Date: 01/15/2021
Onset Date: 01/01/2021
Rec V Date: 02/04/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Tired; Dizzy; unstable; shoulder/injection site pain; shoulder/injection site pain; Arm pain; This is a spontaneous report from a contactable consumer (patient). An 83-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE), via an unspecified route of administration, on 15Jan2021 (at the age of 83-years-old) at a single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient experienced shoulder/injection site pain and arm pain in Jan2021 and tired, dizzy, and unstable on 16Jan2021. The clinical course was reported as follows: The patient initially experienced shoulder/injection site pain and arm pain. On the next day after vaccination, she felt tired, dizzy and unstable. The day after was much better and on the fourth day after vaccination, she was back to normal. The clinical outcome of shoulder/injection site pain, arm pain, tired, dizzy, and unstable was recovered on 18Jan2021. No follow-up attempts are possible; information about lot/batch number cannot be obtained.

Other Meds:

Current Illness:

ID: 0999979
Sex: F
Age:
State: CO

Vax Date: 01/01/2021
Onset Date: 01/01/2021
Rec V Date: 02/04/2021
Hospital:

Lab Data:

Allergies:

Symptoms: inside of her mouth felt weird; hands starting to tingle and felt a bit numb; hands starting to tingle and felt a bit numb; lower lip started swelling up; This is a spontaneous report from a contactable consumer (patient). A 67-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: unknown), via an unspecified route of administration (left arm) on 01Jan2021 (10:45) at single dose for Covid-19 immunization. Medical history included Hashimoto's thyroiditis, uveitis, and known allergy to some antibiotics, artificial preservatives, artificial colors, many foods like egg, gluten. Concomitant medications included levothyroxine sodium (SYNTHROID), bimatoprost (LUMIGAN), timolol, and vitamin D3; all taken on unspecified dates for an unspecified indication. The patient previously took Benadryl and Aspirin and experienced allergy. The patient was not diagnosed with COVID-19 prior to vaccination. The patient is not pregnant. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. It was reported that an hour after the vaccine (01Jan2021 11:45), the patient's lower lip started swelling up. Then it got worse and the inside of her mouth felt weird on 18Jan2021 (11:45AM). The patient's hands starting to tingle and felt a bit numb on 18Jan2021 (11:45 AM) (as reported-pending clarification). The adverse events resulted in Emergency room/department or urgent care. The patient was treated with Prednisone 40mg. The outcome of event lip swelling was unknown; while the outcome of other events was recovered on an unspecified date in Jan2021. The patient has not been tested for COVID-19 since the vaccination. Information on the lot/batch number has been requested.

Other Meds: SYNTHROID; TIMOLOL; LUMIGAN; VITAMIN D3

Current Illness:

ID: 0999980
Sex: M
Age:
State: LA

Vax Date: 01/14/2021
Onset Date:
Rec V Date: 02/04/2021
Hospital:

Lab Data:

Allergies:

Symptoms: her husband's skin is breaking out; This is a spontaneous report from a contactable consumer (patient's wife) via Pfizer-sponsored program. An 82-year-old male patient received single dose of BNT162B2 (Solution for injection, batch/lot number and exp date not reported), via an unspecified route of administration on 14Jan2021 as Covid-19 Vaccine. The patient's medical history and concomitant medications were not reported. The patient's skin was breaking out (onset date not reported). He took a medicine: diphenhydramine for relief. Reporter was advised by their doctor that his husband can't take the second dose and caller was asking what their option was and asking why he can't take the second dose. The outcome of event was unknown. Information about lot number and expiry date for the suspect product will be requested in follow-up attempts.

Other Meds:

Current Illness:

ID: 0999981
Sex: M
Age:
State: MA

Vax Date: 01/18/2021
Onset Date: 01/18/2021
Rec V Date: 02/04/2021
Hospital:

Lab Data: Test Date: 20210118; Test Name: fever; Result Unstructured Data: Test Result:37.9 Centigrade; Comments: low fever of 37.9C

Allergies:

Symptoms: chills; generalized mild myalgia; low fever of 37.9C; This is a spontaneous report from a non-contactable Pharmacist (patient). A 33-years-old male patient received the second dose of bnt162b2 (BNT162B2) , lot number EL3302, via an unspecified route of administration from 18Jan2021 at 19:30 (at the age of 33-years-old) in the left arm as a SINGLE DOSE for COVID-19 vaccination. Historical vaccination included bnt162b2 (BNT162B2) COVID-19 vaccination, lot number EK5730 on 28Dec2020 at 03:15 PM, dose number 1. The patient medical history was not reported. There were no concomitant medications. The patient has no known allergies. The patient received the vaccine at a hospital. On 18Jan2021 at 22:00, the patient experienced chills, generalized mild myalgia and low fever of 37.9C. Treatment for the events included acetaminophen 1000mg. The patient underwent lab tests and procedures which included body temperature: 37.9 centigrade on 18Jan2021 low fever of 37.9C. Outcome of the chills , generalized mild myalgia and low fever of 37.9C was recovered in Jan2021. Prior to the vaccination the patient was not diagnosed with COVID-19. Since the vaccination the patient had not been tested for COVID-19. No follow-up attempts are possible; information about lot/batch number cannot be obtained.

Other Meds:

Current Illness:

ID: 0999982
Sex: F
Age:
State: MI

Vax Date: 01/18/2021
Onset Date: 01/18/2021
Rec V Date: 02/04/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Tiredness; headache; felt out of it; tingling tongue and lips; tingling tongue and lips; body spasms in abdomen throughout the night; This is a spontaneous report from a contactable other healthcare professional, the patient. A 44-year-old non-pregnant female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE), lot number: EL3248, via an unspecified route of administration on 18Jan2021 at 10:15 (at the age of 44-years-old) as a single dose in the left arm for COVID-19 vaccination. Medical history was not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included Fluoxetine hydrochloride (PROZAC), valaciclovir hydrochloride (VALTREX), Cetirizine hydrochloride (ZYRTEC ALLERGY) all for unknown indications from unknown dates and unknown if ongoing. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient previously took iodine and experienced drug allergy. On 18Jan2021 at 12:00, the patient experienced tiredness, felt out of it, tingling tongue and lips, headache, body spasms in abdomen throughout the night. The patient did not receive any treatment for the events. The clinical outcomes of tiredness, felt out of it, tingling tongue and lips, headache, body spasms in abdomen throughout the night were recovering. It was also reported that since the vaccination, the patient had not been tested for COVID-19.

Other Meds: PROZAC; VALTREX; ZYRTEC ALLERGY

Current Illness:

ID: 0999983
Sex: M
Age:
State: FL

Vax Date: 01/12/2021
Onset Date: 01/12/2021
Rec V Date: 02/04/2021
Hospital:

Lab Data:

Allergies:

Symptoms: arm soreness; headache; fatigue; This is a spontaneous report from a contactable consumer (patient). A 65-years-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, lot number and expiry date not reported), via an unspecified route of administration on 12Jan2021 09:00 at a single dose in the left arm for Covid-19 immunisation. The patient's medical history and concomitant medications were not reported. The patient had no COVID prior to vaccination. The patient had no other vaccine in four weeks. On 12Jan2021, the patient experienced arm soreness, headache, and fatigue. No treatments received in response to the events reported. The patient was not tested for COVID post vaccination. The patient recovered from the events arm soreness, headache, and fatigue in Jan2021. Information about Lot/Batch number is requested.

Other Meds:

Current Illness:

ID: 0999984
Sex: M
Age:
State: IN

Vax Date: 12/29/2020
Onset Date: 12/29/2020
Rec V Date: 02/04/2021
Hospital:

Lab Data:

Allergies:

Symptoms: started chills after few hours of vaccination; bodyache; This is a spontaneous report from a contactable other healthcare professional (HCP) (patient). A 46-years-old male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number and expiration date: unknown), via an unspecified route of administration on 29Dec2020 at 11:15 at a single dose for COVID-19 Immunization. Medical history included COVID-19 prior vaccination. The patient had no known allergies. Concomitant medications included atorvastatin (ATORVASTATIN) and multivitamins. The patient had no other vaccine in four weeks. The patient had not tested for COVID post-vaccination. The patient started having chills after a few hours of vaccination and body ache on 29Dec2020. No treatment administered for the events. The events resolved on an unspecified date. Information on the lot/batch number has been requested.

Other Meds: ATORVASTATIN

Current Illness:

ID: 0999985
Sex: F
Age:
State: NC

Vax Date: 01/19/2021
Onset Date: 01/19/2021
Rec V Date: 02/04/2021
Hospital:

Lab Data:

Allergies:

Symptoms: slurred speech/ responded slowly to questions within 2 hours of receiving the vaccine; dilated pupils; "foggy."; This is a spontaneous report from a contactable other hcp. A 60-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Lot number: EL3248), intramuscular on 19Jan2021 09:15 at a SINGLE DOSE for covid-19 immunisation. Medical history included hypertension and oedema. Concomitant medication included phentermine hydrochloride (ADIPEX-P), olmesartan medoxomil (BENICAR), furosemide (LASIX), amlodipine besilate (NORVASC), doxycycline (VIBRAMYCIN). The patient previously took Ciprofloxacin, Clopidogrel, Meperidine, Flagyl, Macrobid, Penbutolol and experienced drug hypersensitivity. The patient had the first dose of vaccine on 20Dec2020 (Lot number=EK5730). The patient exhibited slurred speech, dilated pupils and responded slowly to questions within 2 hours of receiving the vaccine. The patient felt like she just woke up from anesthesia and was "foggy" and 19Jan2021. The outcome of the events was unknown.

Other Meds: ADIPEX-P; BENICAR; LASIX; NORVASC; VIBRAMYCIN

Current Illness:

ID: 0999986
Sex: F
Age:
State: CT

Vax Date:
Onset Date:
Rec V Date: 02/04/2021
Hospital:

Lab Data: Test Name: Covid; Test Result: Positive

Allergies:

Symptoms: Has early signs of covid; tested positive on covid; This is a spontaneous report from a Pfizer-sponsored program received from a contactable consumer. A female patient of an unspecified age received 2 doses of bnt162b2 (Pfizer-BioNTech COVID-19 mRNA vaccine), via an unspecified route of administration on an unspecified date at a single dose for covid-19 immunisation. The patient's medical history and concomitant medications were not reported. On an unspecified date, the patient reported that she has early signs of covid. She tested positive for covid n unspecified date. Information on the Batch/Lot number has been requested.

Other Meds:

Current Illness:

ID: 0999987
Sex: F
Age:
State:

Vax Date: 01/12/2021
Onset Date: 01/14/2021
Rec V Date: 02/04/2021
Hospital:

Lab Data: Test Name: POC rapid COVID test; Result Unstructured Data: Test Result:two negative tests; Comments: before getting the vaccine; Test Date: 20210114; Test Name: POC rapid COVID test; Result Unstructured Data: Test Result:positive

Allergies:

Symptoms: She tested positive for COVID-19 following the first dose; She tested positive for COVID-19 following the first dose; This is a spontaneous report from a contactable healthcare professional. A 27-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot number: EJ1686, expiration date:Mar2021), via an unspecified route of administration (left arm) on 12Jan2021 at a single dose for COVID-19 immunization. The patient's medical history was not reported. There were no concomitant medications. The patient was asking when she can receive the second dose of the COVID vaccine if she tested positive for COVID-19 following the first dose. She received the first dose of the vaccine on 12Jan2021 and tested positive for COVID-19 on 14Jan2021. The patient underwent lab tests and procedures which included POC rapid COVID test: two negative tests on unspecified date, before getting the vaccine, she is tested twice weekly for work, and positive on 14Jan2021. The outcome of the events was not recovered.; Sender's Comments: Based on the information currently available, lack of efficacy of the suspected vaccine BNT162B2 cannot be completely excluded. However, individuals may not be protected until at least 7 days after their second dose of the vaccine. It is unlikely that the patient would have fully developed immunity due to the very short time lag between the first vaccine dose and the event onset.

Other Meds:

Current Illness:

ID: 0999988
Sex: F
Age:
State: NY

Vax Date: 01/16/2021
Onset Date: 01/16/2021
Rec V Date: 02/04/2021
Hospital:

Lab Data: Test Date: 20210116; Test Name: fever; Result Unstructured Data: Test Result:101.9 (Degree); Comments: experienced fever of 101.9(Degree)

Allergies:

Symptoms: tired; fever; chills; aches/achy; swollen lymph node under arm; This is a spontaneous report from a contactable other hcp. This report was received via a sales representative. A 29-years-old female patient received the second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, batch/lot number and expiration date unknown), via an unspecified route of administration on 16Jan2021 at single dose for covid-19 immunisation. The patient medical history was not reported. The patient's concomitant medications were not reported. It is reported that 13 hours after administration on 16Jan2021, patient experienced fever of 101.9 (degree), chills, aches, swollen lymph node under arm. One day later on 17Jan2021, patient was tired and achy. Outcome of the events was unknown. Information on the lot/batch number has been requested.

Other Meds:

Current Illness:

ID: 0999989
Sex: F
Age:
State: IL

Vax Date: 01/16/2021
Onset Date: 01/16/2021
Rec V Date: 02/04/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Patient's arm was sore and bruised; some of the fluid dripped down her arm/"all of the vaccine came out and dripped down to her wrist"; some of the fluid dripped down her arm/"all of the vaccine came out and dripped down to her wrist"; some of the fluid dripped down her arm/"all of the vaccine came out and dripped down to her wrist"; it hit the bone/ it was given in bone; it hit the bone and after the nurse pulled back the needle, some of the fluid dripped down my arm; "it hit the bone"/When it was given it felt like cracking in her bone; patient's arm was sore and bruised; This is a spontaneous report from a contactable nurse. A 64-year-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), (lot number: EL3248), via an unspecified route of administration in the left arm, on 16Jan2021 08:15 at SINGLE DOSE for COVID-19 immunization. Patient had no relevant medical history. The patient's concomitant medications were not reported. The patient stated that during vaccination last Saturday(16Jan2021), "it hit the bone". The nurse pulled back the needle and after that some of the fluid dripped down her arm. Then it was further reported that it was given in bone and "all of the vaccine came out and dripped down to her wrist". Hence, they wanted to know if patient should get it re-administered or get another half dose. Patient's arm was sore and bruised, the first day was so sore but it was getting better. When it was given it felt like cracking in her bone and she thought the needle broke. After the nurse withdrew the needle, she was told it was not broken but said the needle must have gone to the bone. The outcome of event "patient's arm was sore and bruised" was recovering whereas the outcome of all other events was unknown. No follow-up attempts are possible. No further information is expected. Information on the lot/batch number has been obtained.

Other Meds:

Current Illness:

ID: 0999990
Sex: M
Age:
State: AZ

Vax Date: 12/28/2020
Onset Date:
Rec V Date: 02/04/2021
Hospital:

Lab Data: Test Date: 20210115; Test Name: COVID; Result Unstructured Data: Test Result:Positive; Test Date: 20210118; Test Name: COVID; Result Unstructured Data: Test Result:Positive

Allergies:

Symptoms: positive for COVID; positive for COVID; This is a spontaneous report from a Pfizer Sponsored Program from a contactable consumer (patient). A 52-year-old male patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) Lot number EH9899, on 28Dec2020 at single dose for COVID-19 immunization. Medical history and concomitant medications were not reported. The patient took the first dose of the Pfizer COVID Vaccine on 28Dec2020. After that he showed positive for COVID. He was scheduled for the second dose today (18Jan2021). He had taken a COVID test and tested positive for COVID. He was trying to re-schedule an appointment. They told him to contact his doctor, which he did. His doctor had suggested that he took the second booster on 24Jan2021, instead of today. The patient took a covid test Last Friday (15Jan2021) and tested positive also, He didn't believe the results so he tested again today (18Jan2021) and the result was also positive. Both tests were rapid tests. What made him take the test, the following Wednesday, he had a dry cough. He took OTC cough medicine and it stopped the dry cough. No other symptoms, not coughing today. The outcome of the events was unknown.

Other Meds:

Current Illness:

ID: 0999991
Sex: F
Age:
State: FL

Vax Date: 01/04/2021
Onset Date: 01/04/2021
Rec V Date: 02/04/2021
Hospital:

Lab Data: Test Date: 202101; Test Name: lungs checked; Result Unstructured Data: Test Result:clear; Test Date: 202101; Test Name: testing; Result Unstructured Data: Test Result:Normal; Test Name: oxygen level; Result Unstructured Data: Test Result:good; Test Date: 202101; Test Name: oxygen level; Result Unstructured Data: Test Result:Normal; Test Name: COVID test; Test Result: Negative ; Test Date: 20210111; Test Name: COVID test; Result Unstructured Data: Test Result:Positive

Allergies:

Symptoms: positive for COVID; positive for COVID; cough; She felt lethargic and had a dull headache; She felt lethargic and had a dull headache; Her arm hurt the night of the vaccine and the following day; This is a spontaneous report from a contactable consumer (patient) via a Pfizer-sponsored program, Pfizer First Connect. This consumer (patient) reported similar events for two patients (patient's husband and patient). This is the first of two reports. A 72-years-old female patient received first dose of bnt162b2 (BNT162B2, Lot EH9899), via an unspecified route of administration on 04Jan2021 at single dose for covid-19 immunisation. Medical history included cholesterol. Concomitant medication included pravastatin sodium (PRAVACOR) for cholesterol, levothyroxine sodium (SYNTHROID), she had been taking both at least 10 years and were ongoing. The patient experienced her arm hurt the night of the vaccine and the following day since 04Jan2021. She had been tested a few times. Tested in (state) and then came to (state). Quarantined for two weeks and test were negative. She had COVID testing on 11Jan2021 and got results were 13Jan2021. She experienced positive for covid on 11Jan2021, cough and she felt lethargic and had a dull headache on 06Jan2021, she had a mild case, did not have a fever, she went to the walk in clinic, had lungs checked, her oxygen level was normal, she had been testing normal, she did not have any severe symptoms of the COVID, she got post nasal drip and She started Azithromycin on 11Jan2021. The patient was such a careful person. When she went to the supermarket, she wore a shield, mask, and gloves. She did not socialize, was home body. She had no idea how she got it. She did call her internist when she found out she had it. The patient underwent lab tests and procedures which included oxygen level: normal in Jan2021, oxygen level: good on an unknown date, COVID test: negative on an unknown date, COVID test: positive on 11Jan2021, lung checked: clear in Jan2021, testing: normal in Jan2021. The even outcome was unknown.

Other Meds: PRAVACOR; SYNTHROID

Current Illness:

ID: 0999992
Sex: U
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 02/04/2021
Hospital:

Lab Data: Test Name: Covid; Test Result: Positive

Allergies:

Symptoms: patient tested positive for Covid after receiving the first dose; patient tested positive for Covid after receiving the first dose; This is a spontaneous report from a contactable consumer. This consumer reported similar events for 7 patients. This report is for 1st of 7 patient. A patient of unspecified age and gender received the first dose of bnt162b2 (BNT162B2 also reported as Pfizer Covid vaccine, lot/batch number and expiry date were not reported), via an unspecified route of administration on an unspecified date at SINGLE DOSE for Covid-19 immunisation. The patient's medical history and concomitant medications were not reported. The consumer reported that 7 coworkers was tested positive for Covid after receiving first dose of the Pfizer Covid vaccine on an unspecified date. The outcome of event was unknown. No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.; Sender's Comments: Linked Report(s) : 2021045638 same drug/AE, different patient;2021045639 same drug/AE, different patient;2021045643 same drug/AE, different patient;2021045641 same drug/AE, different patient;2021045642 same drug/AE, different patient;2021045640 same drug/AE, different patient;US-PFIZER INC-2021045639 same drug/AE, different patient

Other Meds:

Current Illness:

ID: 0999993
Sex: U
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 02/04/2021
Hospital:

Lab Data: Test Name: Covid-19; Test Result: Positive

Allergies:

Symptoms: patient tested positive for Covid after receiving the first dose; patient tested positive for Covid after receiving the first dose; This is a spontaneous report from a contactable consumer. This consumer reported similar events for 7 patients. This report is for 2nd of 7 patients. A patient of unspecified age and gender received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot/batch number and expiry date were not reported), via an unspecified route of administration on an unspecified date at a single dose for Covid-19 immunisation. The patient's medical history and concomitant medications were not reported. The consumer reported that patient tested positive for COVID after receiving the first dose of the vaccine on an unspecified date. The outcome of events was unknown. No follow up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.; Sender's Comments: Linked Report(s) : US-PFIZER INC-2021045622 same drug/AE, different patient

Other Meds:

Current Illness:

ID: 0999994
Sex: U
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 02/04/2021
Hospital:

Lab Data: Test Name: COVID-19; Test Result: Positive

Allergies:

Symptoms: patient tested positive for Covid after receiving the first dose; patient tested positive for Covid after receiving the first dose; This is a spontaneous report from a contactable consumer. This consumer reported same event for seven patients. This is the third of 7 reports. A patient of unspecified age and gender received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot number and expiry date were not reported), via an unspecified route of administration on an unspecified date at a single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. It was reported that seven (7) coworkers tested positive for COVID after receiving 1st dose of the Pfizer Covid vaccine on an unspecified date. The outcome of the events was unknown. No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.; Sender's Comments: Linked Report(s) : US-PFIZER INC-2021045622 same drug/AE, different patient

Other Meds:

Current Illness:

ID: 0999995
Sex: U
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 02/04/2021
Hospital:

Lab Data: Test Name: Covid; Test Result: Positive

Allergies:

Symptoms: patient tested positive for Covid after receiving the first dose; patient tested positive for Covid after receiving the first dose; This is a spontaneous report from a contactable consumer. This consumer reported the same event for seven (7) patients. This is the fourth of the seven (7) reports. A patient of unspecified age and gender received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) Solution for injection (lot number and expiry date unknown) via an unspecified route of administration on an unspecified date at a single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The consumer reported that seven (7) coworkers/ patients tested positive for Covid on an unspecified date after receiving the first dose of the Pfizer Covid vaccine. The outcome of the event was unknown. No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.; Sender's Comments: Linked Report(s) : US-PFIZER INC-2021045622 same reporter/drug/event, different patient.

Other Meds:

Current Illness:

ID: 0999996
Sex: U
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 02/04/2021
Hospital:

Lab Data: Test Name: Covid; Test Result: Positive

Allergies:

Symptoms: patient tested positive for Covid after receiving the first dose; patient tested positive for Covid after receiving the first dose; his is a spontaneous report from a contactable consumer. This consumer reported similar events for seven patients. This report is for the sixth of seven patients. A patient of unspecified age and gender received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, also reported as Pfizer Covid vaccine, lot/batch number and expiry date were not reported), via an unspecified route of administration on an unspecified date at a single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient tested positive for Covid after receiving the first dose of the Pfizer Covid vaccine on an unspecified date. The outcome of event was unknown. No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.; Sender's Comments: Linked Report(s) : US-PFIZER INC-2021045622 same drug/AE, different patient.

Other Meds:

Current Illness:

ID: 0999997
Sex: M
Age:
State: FL

Vax Date: 01/04/2021
Onset Date: 01/13/2021
Rec V Date: 02/04/2021
Hospital:

Lab Data: Test Name: lungs checked; Result Unstructured Data: Test Result:clear; Test Name: oxygen level; Result Unstructured Data: Test Result:Normal; Test Name: oxygen level; Result Unstructured Data: Test Result:Good; Test Name: COVID; Test Result: Negative ; Test Date: 20210113; Test Name: COVID; Test Result: Positive

Allergies:

Symptoms: both have COVID; both have COVID; The initial case was missing the following minimum criteria: unspecified product. Upon receipt of follow-up information on 15Jan2021, this case now contains all required information to be considered valid. This is a spontaneous report from two contactable consumers (patient's wife and patient) via a Pfizer-sponsored program, Pfizer First Connect. This consumer (patient's wife) reported similar events for two patients. This is the second of two reports. A 74-year-old male patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Solution for injection, lot number: EH9899, unknown expiration), via an unspecified route of administration on 04Jan2021 at a single dose for COVID-19 immunization in a clinic. Medical history included prostate cancer, off rapid radiation (over two years ago by robotic surgery. He followed all the recommendations for rapid off radiation, no side effects. He took hormone therapy. He is cured), acid reflux, allergies (takes antihistamine when allergies act up; his allergies blossomed because of the leaves), and he used to be five nine, but he shrunk a little. Concomitant medications included rosuvastatin, acetylsalicylic acid (BABY ASPIRIN), losartan, pantoprazole for he had a bout with acid reflux, and tadalafil. The patient's wife and the patient both received the COVID-19 vaccine on 04Jan2021 and stated they have a mild case; they did not have any severe symptoms of the COVID and did not have a fever. The patient's oxygen level was normal. The patient's wife confirmed that she and her husband both had the vaccine on the same day and they both have COVID. The patient got a cough and was going to go the (clinic name). They went there and had lungs checked. Their lungs were clear and oxygen level was good. They both have been tested a few times. The patient's wife and the husband quarantined for two weeks and test were negative. When they were there this past Monday, they were asked if they wanted to be tested. They both got the results on Wednesday and were shocked; they were now quarantining again. COVID testing was done on 11Jan2021 and got the positive results on 13Jan2021. The patient's wife and the husband gave them a card, for when to come back. It was given at a drive through clinic in (county name). The patient feels fine and is sleeping well. The patient recovered from the event in Jan2021.; Sender's Comments: Linked Report(s) : US-PFIZER INC-2021045610 same reporter/drug, similar events in different patients

Other Meds: ROSUVASTATIN; BABY ASPIRIN; LOSARTAN; PANTOPRAZOLE; TADALAFIL

Current Illness:

ID: 0999998
Sex: F
Age:
State: TX

Vax Date: 01/15/2021
Onset Date: 01/15/2021
Rec V Date: 02/04/2021
Hospital:

Lab Data:

Allergies:

Symptoms: allergic reaction with welts on the body and face; allergic reaction with welts on the body and face; severe itching; This is a spontaneous report from a contactable pharmacist (patient's husband). A 46-year-old female patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EL1284, Expiry Date: Apr2021, NDC number: 59267100002), intramuscular on 15Jan2021 ("8:30 8:45 PM ") at 0.3 mL, single on "left hip" (as reported) for COVID-19 immunization. Medical history included none. There were no concomitant medications. The first dose of the vaccine was given on 15Jan2021. The pharmacist (patient's husband) drew it up at the pharmacy and took the syringe home and gave it to her at home. He had been doing some of the clinics so he wanted her to get vaccinated just in case. Patient experienced an allergic reaction with welts on the body and face, and severe itching. The whelps on the body started Friday 15Jan2021 and they have resolved completely at this time. Patient's husband says her severe itching started 15Jan2021 and have also resolved completely at this time (also reported as "whelps and itching developed about 10 PM 18Jan2021"). The outcome of the events was recovered on an unspecified date. The adverse events did not require a visit to emergency room or physician office. The seriousness and causality were not provided. No prior vaccinations (within 4 weeks). No adverse events following prior vaccinations.

Other Meds:

Current Illness:

ID: 0999999
Sex: F
Age:
State: CA

Vax Date: 01/15/2021
Onset Date: 01/16/2021
Rec V Date: 02/04/2021
Hospital:

Lab Data:

Allergies:

Symptoms: a background headache all day; lethargy; bit of fogginess; This is a spontaneous report from a consumer, the patient. A 69-year-old non-pregnant female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EL3302), via an unspecified route of administration, in the right arm on 15Jan2021 at 15:30PM (at the age of 69-year-old) as a single dose for COVID-19 immunization. Medical history included just sensitivities, not allergies, to NSAIDS and some pain meds. Prior to the vaccination, the patient was not diagnosed with COVID-19. There were no concomitant medication taken within two weeks of vaccination. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient reported that on the first day nothing. On 16Jan2021, the second day (as reported), the patient experienced lethargy and a bit of fogginess. The third day, 17Jan2021, the patient had a background headache all day. The events were reported as non-serious. The patient finally took (acetaminophen) TYLENOL before bed, for the headache, waking on the fourth day feeling normal. The clinical outcome of the events lethargy, bit of fogginess, a background headache all day was recovered. It was also reported that since the vaccination, the patient had not been tested for COVID-19.

Other Meds:

Current Illness:

ID: 1000000
Sex: M
Age:
State: CA

Vax Date:
Onset Date:
Rec V Date: 02/04/2021
Hospital:

Lab Data: Test Name: Covid; Test Result: Positive

Allergies:

Symptoms: tested positive; tested positive; This is a spontaneous report from a contactable nurse (patient) via a Pfizer-sponsored program. A male patient of unspecified age received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; unknown lot number and expiration), via an unspecified route of administration on an unspecified date at a single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient received his first shot a couple of weeks ago but tested positive later that day. The patient wanted to know how effective the vaccine was. The patient underwent lab test and procedure which included COVID: positive on unspecified date. Outcome of the event was unknown. Information on the batch/lot number has been requested.; Sender's Comments: There is not a reasonable possibility that event "tested positive" is related to BNT162B2. The event occurred on the same day the patient got vaccination, when the vaccine is not expected to achieve the protection. The event is most likely intercurrent medical condition.

Other Meds:

Current Illness:

ID: 1000001
Sex: F
Age:
State: WI

Vax Date: 12/28/2020
Onset Date: 12/28/2020
Rec V Date: 02/04/2021
Hospital:

Lab Data: Test Name: covid; Test Result: Positive

Allergies:

Symptoms: covid symptoms the 28th and tested positive; covid symptoms the 28th and tested positive; This is a spontaneous report from a Pfizer sponsored program from a contactable Nurse (patient). A female patient of an unspecified age received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on 28Dec2020 around 2 pm at single dose for covid-19 immunisation. The patient medical history and concomitant medications were not reported. On 28Dec2020 the patient experienced covid symptoms the 28th and tested positive. The patient underwent lab tests and procedures which included covid test positive on unknown date. The outcome was unknown. The information on the batch/lot number has been requested.; Sender's Comments: The patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE) on 28Dec2020, and COVID-19 test positive on the same day. No effect of the suspect vaccine could be reasonably achieved to protect from the targeted infection/disease due to the very short time lag. Instead, the positive COVID likely represents a pre-existing infection prior to vaccine use. Further information is needed for full medical assessment.

Other Meds:

Current Illness:

ID: 1000002
Sex: M
Age:
State: NC

Vax Date: 01/19/2021
Onset Date: 01/19/2021
Rec V Date: 02/04/2021
Hospital:

Lab Data:

Allergies:

Symptoms: his lymph nodes to his neck are swollen; This is a spontaneous report from a contactable consumer (patient). An 85-year-old male patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot/batch number and expiration date were unknown), via an unspecified route of administration on 19Jan2021 13:30 at a single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient's lymph nodes in his neck were swollen on 19Jan2021 at 17:30. It was more on the left side. The patient has not recovered from the event. Information on the batch/lot number has been requested.

Other Meds:

Current Illness:

ID: 1000003
Sex: F
Age:
State: PA

Vax Date: 01/17/2021
Onset Date: 01/18/2021
Rec V Date: 02/04/2021
Hospital:

Lab Data:

Allergies:

Symptoms: rash and hives all over body; rash and hives all over body; This is a spontaneous report from a contactable healthcare professional (reported for herself). A 29-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection; lot number: EJ1685; expiry date: not known), intramuscular in the left arm on 17Jan2021 08:30 at single dose for COVID-19 immunization. There was no medical history. The patient is not pregnant. No known allergies. Concomitant medication included unspecified medication (other medication given in two weeks). No other vaccine in four weeks. No COVID prior to vaccination and not tested with COVID post vaccination. The patient experienced rash and hives all over body on 18Jan2021 11:00. These resulted in physician's clinic visit. Therapeutic measures were taken as a result of rash and hives all over body with prednisone, Benadryl, and Kenalog. The outcome of the events was recovered in Jan2021.

Other Meds:

Current Illness:

ID: 1000004
Sex: F
Age:
State: CA

Vax Date: 01/08/2021
Onset Date: 01/10/2021
Rec V Date: 02/04/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Itchy rash on bilateral elbow; This is a spontaneous report from a contactable pharmacist. A 61-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; lot number: EL3246), via intramuscular route of administration on 08Jan2021 at a single dose in the left arm for COVID-19 immunization. Medical history was reported as none. Concomitant medications were not reported. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. On 10Jan2021, the patient experienced itchy rash on bilateral elbow. The patient did not receive any treatment for the reported event. The patient was not pregnant at the time of vaccination. The outcome of the event was recovering.

Other Meds:

Current Illness:

Total 2021 VAERS Injuries: 134,999

Page last modified: 14 December 2021 10:42pm